Can Diver-Style breathing clear your stuffy nose?
NCT ID NCT07455968
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study looks at whether a breathing technique used by free divers can reduce symptoms of allergic rhinitis, like nasal congestion and sneezing. Thirty adults with persistent allergies will practice the 40-minute breathing sessions. Researchers will measure symptom scores, nasal airflow, and other markers to see if the training helps.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- free diving breathing training
- What this could lead to
- If it works, this could offer a simple, drug-free way to reduce nasal congestion and other allergy symptoms.
- What could go wrong
- This is a very small early study with only 30 people, so results may not apply widely. The breathing technique may be hard to do correctly or may not help everyone.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 30 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Aug 2025
- Expected to finish
-
Mar 2026
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 35 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Patients diagnosed with persistent allergic rhinitis (allergen of any type), both male and female, presenting with nasal congestion, sneezing, nasal itching, and rhinorrhea occurring more than 4 days per week, with an average symptom score greater than 7. Eligibility was determined using the Rhinitis Symptoms Score (0, 1, 2, and ≥3 scale) assessed over the previous week and on the day of testing. Participants must not have any complications such as sinusitis, Eustachian tube dysfunction, or asthma. * No history of other respiratory diseases, including bronchitis, pertussis, pneumonia, pneumonitis, pulmonary aspergilloma, tuberculosis, asthma, lung cancer, emphysema, or other related conditions. * No regular exercise training exceeding 20 minutes per session, 3 days per week or more, during the 6 months prior to participation. * No regular consumption of vitamin supplements or herbal products at least 3 days per week during the 6 months prior to participation. * Ability to discontinue the following medications before and during the study period: Antihistamines for at least 3 days, Oral steroids and nasal steroids for at least 2 weeks, Leukotriene receptor antagonists for at least 1 week * Participants were permitted to use decongestants (pseudoephedrine) if necessary. All participants were advised to consult their primary physician before discontinuing any medication and to ensure that their physical condition was appropriate for participation in the breathing training program. * Willingness to participate voluntarily and provide written informed consent. Exclusion Criteria: * Inability to continue participation due to unforeseen circumstances, such as injury or illness. * Absence from more than 8 training sessions out of a total of 40 sessions. * Withdrawal of consent or unwillingness to continue participation. * Inability to discontinue medications according to the specified criteria. * Exacerbation of allergic rhinitis symptoms that prevents continued participation, such as persistent rhinorrhea or severe nasal congestion causing difficulty breathing.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Allergic rhinitis are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Faculty of Sports Science, Chulalongkorn University
Bangkok, Bangkok, 10330, Thailand
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Protein periostin probed as possible driver of childhood adenoid overgrowth
- Can a needle in the face tame allergy symptoms?
- Can AI make acupuncture more precise for allergy relief?
- Ancient herbal blend put to the test against hay fever
- Can a pinpoint pollen dose unmask allergy triggers?
- Can an antihistamine–steroid combo pill beat standard allergy meds?